Shanghai Changzheng Hospital

This early-phase trial tests a new treatment called PSMA-UCAR T cells for men with advanced prostate cancer that no longer responds to standard therapies. The therapy uses specially engineered immune cells to target a protein (PSMA) on cancer cells. The main goal is to check safe…

This study compares two surgical methods for severe cervical ossification of the posterior longitudinal ligament (OPLL), a condition where bone spurs form in the spine and can compress the spinal cord. The trial involves 167 adults aged 18-70 who will receive either a newer proce…

This early-phase trial tests a new treatment for men with a tough-to-treat form of advanced prostate cancer. The therapy uses the patient's own immune cells, which are modified in a lab to better recognize and attack cancer cells. The main goals are to check if the treatment is s…

This early-stage trial tests whether combining two lab-made antibodies can help control metastatic castration-resistant prostate cancer (mCRPC), a tough-to-treat form of prostate cancer. Seven men with advanced disease will receive the drug combo and be monitored for side effects…